All In MedTech

Device Trial Radar · NCT00851279

Stereotaxis Study To Obliterate Persistent Ventricular Tachycardia

Stereotaxis Study To Obliterate Persistent Ventricular Tachycardia: Data Collection of Clinical Scar-related VT Cases

Last checked: Nov 20, 2026Latest source record: Aug 24, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

53

Actual

Start

Jun 2009

Primary completion

Oct 2012

Study completion Apr 2013

Sponsor

Lead sponsor
StereotaxisPublic (STXS)
Sponsor type
Industry
First posted
Feb 25, 2009

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective, non-randomized, multi-center clinical case series evaluating the outcomes of the magnetic navigation system in ventricular tachycardia (VT) cases. Subjects will be evaluated acutely and will be followed clinically at 1, 6 and 12 months post-treatment.

Conditions

  • Ventricular Tachycardia

Interventions

  • Magnetic irrigated ablation catheterDevice

    Magnetic irrigated catheter to be used with the magnetic navigation system

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Free From VT at 1 Year Post-TreatmentTime frame: 1 Year follow-up

Locations

4 sites in 3 countries. Site status is shown where the registry gives one.

  • Krannert Institute of Cardiology

    Indianapolis, Indiana

  • Hospital of the University of Pennsylvania

    Philadelphia, Pennsylvania

  • Na Homolce Hospital

    Prague, Czechia

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.